JP2021508728A5 - - Google Patents

Info

Publication number
JP2021508728A5
JP2021508728A5 JP2020536766A JP2020536766A JP2021508728A5 JP 2021508728 A5 JP2021508728 A5 JP 2021508728A5 JP 2020536766 A JP2020536766 A JP 2020536766A JP 2020536766 A JP2020536766 A JP 2020536766A JP 2021508728 A5 JP2021508728 A5 JP 2021508728A5
Authority
JP
Japan
Prior art keywords
injectable composition
composition according
compound represented
formula
vesicles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020536766A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021508728A (ja
JP7378401B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/067216 external-priority patent/WO2019135954A1/en
Publication of JP2021508728A publication Critical patent/JP2021508728A/ja
Publication of JP2021508728A5 publication Critical patent/JP2021508728A5/ja
Priority to JP2023187032A priority Critical patent/JP2024012452A/ja
Application granted granted Critical
Publication of JP7378401B2 publication Critical patent/JP7378401B2/ja
Priority to JP2025060460A priority patent/JP2025106349A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020536766A 2018-01-02 2018-12-21 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物 Active JP7378401B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023187032A JP2024012452A (ja) 2018-01-02 2023-10-31 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物
JP2025060460A JP2025106349A (ja) 2018-01-02 2025-04-01 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862612893P 2018-01-02 2018-01-02
US62/612,893 2018-01-02
PCT/US2018/067216 WO2019135954A1 (en) 2018-01-02 2018-12-21 Injectable compositions of triterpenoid antifungals encapsulated in liposomes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023187032A Division JP2024012452A (ja) 2018-01-02 2023-10-31 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物

Publications (3)

Publication Number Publication Date
JP2021508728A JP2021508728A (ja) 2021-03-11
JP2021508728A5 true JP2021508728A5 (cg-RX-API-DMAC7.html) 2022-03-24
JP7378401B2 JP7378401B2 (ja) 2023-11-13

Family

ID=65024141

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020536766A Active JP7378401B2 (ja) 2018-01-02 2018-12-21 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物
JP2023187032A Withdrawn JP2024012452A (ja) 2018-01-02 2023-10-31 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物
JP2025060460A Pending JP2025106349A (ja) 2018-01-02 2025-04-01 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023187032A Withdrawn JP2024012452A (ja) 2018-01-02 2023-10-31 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物
JP2025060460A Pending JP2025106349A (ja) 2018-01-02 2025-04-01 リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物

Country Status (27)

Country Link
US (3) US20200338002A1 (cg-RX-API-DMAC7.html)
EP (2) EP4137123A1 (cg-RX-API-DMAC7.html)
JP (3) JP7378401B2 (cg-RX-API-DMAC7.html)
KR (1) KR102694692B1 (cg-RX-API-DMAC7.html)
CN (2) CN115998684A (cg-RX-API-DMAC7.html)
AU (1) AU2018399599B2 (cg-RX-API-DMAC7.html)
CA (1) CA3087176A1 (cg-RX-API-DMAC7.html)
DK (1) DK3735226T3 (cg-RX-API-DMAC7.html)
EA (1) EA202091626A1 (cg-RX-API-DMAC7.html)
ES (1) ES2927051T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20221295T1 (cg-RX-API-DMAC7.html)
HU (1) HUE060400T2 (cg-RX-API-DMAC7.html)
IL (2) IL275758B2 (cg-RX-API-DMAC7.html)
LT (1) LT3735226T (cg-RX-API-DMAC7.html)
MA (1) MA51514A (cg-RX-API-DMAC7.html)
MD (1) MD3735226T2 (cg-RX-API-DMAC7.html)
MX (1) MX2020006992A (cg-RX-API-DMAC7.html)
PL (1) PL3735226T3 (cg-RX-API-DMAC7.html)
PT (1) PT3735226T (cg-RX-API-DMAC7.html)
RS (1) RS63687B1 (cg-RX-API-DMAC7.html)
SA (1) SA520412362B1 (cg-RX-API-DMAC7.html)
SG (1) SG11202006313WA (cg-RX-API-DMAC7.html)
SI (1) SI3735226T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202200427T1 (cg-RX-API-DMAC7.html)
TW (2) TWI857944B (cg-RX-API-DMAC7.html)
UA (1) UA126096C2 (cg-RX-API-DMAC7.html)
WO (1) WO2019135954A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7378401B2 (ja) * 2018-01-02 2023-11-13 サイネクシス,インコーポレーテッド リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
US7718189B2 (en) * 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
NZ589967A (en) * 2004-01-14 2012-07-27 Gilead Sciences Inc Lipid-based dispersions useful for drug delivery
ES2402659T3 (es) 2006-04-03 2013-05-07 Merck Sharp & Dohme Corp. Derivados de enfumafungina como agentes antifúngicos
CA2700530C (en) * 2007-09-28 2014-12-09 Merck Sharp & Dohme Corp. Antifungal agents
US8226965B2 (en) * 2008-04-25 2012-07-24 Nanobio Corporation Methods of treating fungal, yeast and mold infections
JP2011529038A (ja) * 2008-07-23 2011-12-01 ターゲッティド デリバリー テクノロジーズ リミテッド 真菌感染症の処置のための局所抗真菌製剤の投与方法
WO2010019204A1 (en) * 2008-08-12 2010-02-18 Merck Sharp & Dohme Corp. Antifungal agents
PE20120923A1 (es) * 2009-03-30 2012-08-27 Eisai Randd Man Co Ltd Composiciones farmaceuticas comprendiendo liposomas que contiene eribulina o una sal del mismo
PT3247711T (pt) * 2015-01-19 2022-05-16 Scynexis Inc Novos sais e polimorfos de scy-078
JP7378401B2 (ja) * 2018-01-02 2023-11-13 サイネクシス,インコーポレーテッド リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物

Similar Documents

Publication Publication Date Title
WO1998033481A1 (en) Lipid complexes and liposomes of highly insoluble platinum complexes
JP5735724B2 (ja) 腹腔内投与される脂質ベースの白金化合物製剤を用いた、癌の治療方法
JP4950890B2 (ja) 動物に対する鉄の送達
JP2025106349A (ja) リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物
US20190343763A1 (en) Methods of treating upper tract urothelial carcinomas
JPH07501825A (ja) 高められた抗真菌活性を有するアンフォテリシンb組成物
JP2019525922A (ja) 癌を治療するための方法および組成物
AU2022393147A1 (en) Formulated and/or co-formulated nanocarriers compositions containing immunogenic cell death (icd) inducing prodrugs useful in the treatment of cancer and methods thereof
JP2022532734A5 (cg-RX-API-DMAC7.html)
NZ765771B2 (en) Injectable compositions of triterpenoid antifungals encapsulated in liposomes
JP2022519500A5 (cg-RX-API-DMAC7.html)
JP7606633B2 (ja) 医薬組成物及びアプレピタント注射液並びに凍結乾燥粉末注射剤
JP2013534523A (ja) 溶解度が向上した難溶性トリサイクリック誘導体の薬学的組成物
US20150056269A1 (en) Liposome comprising at least one cholesterol derivative
HK40036677A (en) Injectable compositions of triterpenoid antifungals encapsulated in liposomes
CN116807975A (zh) 一种具有多室脂质体结构的药物载体制备方法
HK40036677B (en) Injectable compositions of triterpenoid antifungals encapsulated in liposomes
HK40090116A (en) Injectable compositions of triterpenoid antifungals encapsulated in liposomes
JP2022523212A5 (cg-RX-API-DMAC7.html)
HK1194981A (en) Liposome comprising at least one cholesterol derivative